MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1164/rccm.200905-0800oc

Медицинская библиотека · American journal of respiratory and critical care medicine · 2009

Inducible nitric oxide synthase/CD95L-dependent suppression of pulmonary and bone marrow eosinophilia by diethylcarbamazine.

Queto Tulio, Xavier-Elsas Pedro, Gardel Marcelo Aranha, de Luca Bianca, Barradas Mônica, Masid Daniela, E Silva Patricia Machado R, Peixoto Christina A, Vasconcelos Zilton Meira F, Dias Eliane P, Gaspar-Elsas Maria Ignez

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

RATIONALE: The mechanism of action of diethylcarbamazine (DEC), an antifilarial drug effective against tropical pulmonary eosinophilia, remains controversial. DEC effects on microfilariae depend on inducible NO synthase (iNOS). In eosinophilic pulmonary inflammation, its therapeutic mechanism has not been established. We previously described the rapid up-regulation of bone marrow eosinophilopoiesis in ovalbumin (OVA)-sensitized mice by airway allergen challenge, and further evidenced the down-regulation of eosinophilopoiesis by iNOS- and CD95L-dependent mechanisms.

OBJECTIVES

We investigated whether: (1) DEC can prevent the effects of airway challenge of sensitized mice on lungs and bone marrow, and (2) its effectiveness depends on iNOS/CD95L.

METHODS

OVA-sensitized BALB/c mice were intranasally challenged for 3 consecutive days, with DEC administered over a 12-, 3-, or 2-day period, ending at the day of the last challenge. We evaluated: (1) airway resistance, cytokine (IFN-gamma, IL-4, IL-5, and eotaxin) production, and pulmonary eosinophil accumulation; and (2) bone marrow eosinophil numbers in vivo and eosinophil differentiation ex vivo.

MEASUREMENTS AND MAIN

RESULTS

DEC effectively prevented the effects of subsequent challenges on: (1) airway resistance, Th1/Th2 cytokine production, and pulmonary eosinophil accumulation; and (2) eosinophilopoiesis in vivo and ex vivo. Recovery from unprotected challenges included full responses to DEC during renewed challenges. DEC directly suppressed IL-5-dependent eosinophilopoiesis in naive bone marrow. DEC was ineffective in CD95L-deficient gld mice and in mice lacking iNOS activity because of gene targeting or pharmacological blockade.

CONCLUSIONS

DEC has a strong impact on pulmonary eosinophilic inflammation in allergic mice, as well as on the underlying hemopoietic response, suppressing the eosinophil lineage by an iNOS/CD95L-dependent mechanism.

Для цитирования: Queto Tulio, Xavier-Elsas Pedro, Gardel Marcelo Aranha, de Luca Bianca, Barradas Mônica, Masid Daniela, E Silva Patricia Machado R, Peixoto Christina A, Vasconcelos Zilton Meira F, Dias Eliane P, Gaspar-Elsas Maria Ignez. Inducible nitric oxide synthase/CD95L-dependent suppression of pulmonary and bone marrow eosinophilia by diethylcarbamazine.. American journal of respiratory and critical care medicine. 2009. DOI: 10.1164/rccm.200905-0800oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.